In addition, our data revealed that OGDHL (oxoglutarate dehydrogenase like), a main rate-limiting subunit of the 2-oxoglutarate dehydrogenase multienzyme complex, was significantly down-regulated in GBM. The gene discussed is OGDHL; the disease is glioblastoma.